Metrics as of 10/13/2026, 06:50 PM (Berlin time), refresh in progress.
Modular Medical, Inc.
Modular Medical, Inc. is an emerging medical technology company primarily focused on the creation, refinement, and market introduction of insulin pumps. The firm aims to leverage advanced technology to increase the adoption and use of these devices among individuals with diabetes. Its main corporate offices are…
1D
-9.0%
1W
-10.6%
1M
-3.9%
6M
-49.3%
YTD
-77.7%
1Y
-86.8%
2Y
-96.2%
5Y
–
10Y
–
Next earnings date
02/12/2026 (in 46 days)
Volatility around earnings
~12% stronger price swings than usual
0
STRONG BUY
3
BUY
0
HOLD
0
SELL
0
STRONG SELL
3
TOTAL · Buy
As of: 21/03/2024
P/E
-0.24
P/B
1.24
EV/EBITDA
-0.64
RETURN ON EQUITY
-60.3%
NET MARGIN
0.0%
DEBT/EQUITY
0.03
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
FREE FLOAT
87.7%
FLOAT SHARES
7,144,359
AVG. DAILY VOLUME (30D)
172,420
Modular Medical, Inc. is a company in the Healthcare sector, Medical - Devices industry, headquartered in United States.
The CEO is James E. Besser, the company employs around 51 people.
The IPO was on 10/02/2022; the stock trades on NASDAQ under the ticker MODD.
3 analysts rate the stock, the consensus is Buy (as of 21/03/2024).
This is an external assessment, not a statement by Market Jury.
The next earnings date is 02/12/2026.
Around past earnings, price swings were roughly 12% stronger than usual.
No, Modular Medical currently does not pay a dividend.
Comparable stocks include Abbott Laboratories, Stryker, Boston Scientific, Edwards Lifesciences, DexCom, GE HealthCare Technologies, Zimmer Biomet Holdings and Align Technology.
Clicking "Analyze stock" lets five strategies assess Modular Medical against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.